Kyleena 19.5 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FGAU5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,626
Award facts
- Contract value 100% obligated
- $2,626.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,626.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Kyleena 19.5 mg contraceptive systems. The contract, issued on January 22, 2026, with an ultimate completion date of February 12, 2026, utilizes firm fixed-price pricing with no set-aside designation, allowing the vendor to compete in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated consistent performance as a critical supplier within the federal pharmaceutical supply chain, with its PPV-G GEN V contract ceiling valued at approximately $500 million through December 31, 2036. The company's product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, positioning it to fulfill the diverse pharmaceutical requirements of military healthcare operations globally. As a long-standing federal contractor registered in the System for Award Management since 2001, DMS Pharmaceutical Group leverages its small business status and established performance history to serve as a regional pharmaceutical prime vendor supporting recurring medical supply needs across the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FGAU5?
SPE2DR26FGAU5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FGAU5 worth?
The government has obligated $2,626 on SPE2DR26FGAU5.
Is contract SPE2DR26FGAU5 an order under another contract?
Yes. SPE2DR26FGAU5 is a delivery order under SPE2DR25D9371, an indefinite delivery contract.
Was contract SPE2DR26FGAU5 competed?
The extent of competition for SPE2DR26FGAU5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award